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1. Introduction
Deoxyribonucleid acid (DNA) is made of monomeric nucleotide 
(nt) building blocks that are covalently linked to each other by 
phosphodiester bonds. According to Watson–Crick base pairing 
rules, the four different nucleotides, adenine (A), thymine 
(T), cytosine (C), and guanine (G), selectively form hydrogen 
bonded base pair (bp) dimers in a way that A and C exclusively 
pair with T and G, respectively, thereby giving rise to formation 
of the well-known DNA double helix.[1] In pioneering work, 
Nadrian Seeman proposed in 1982 to use DNA as a construc-
tion material for the assembly of geometrically defined objects 
with nanoscale features.[2] This rather unconventional and revo-
lutionary concept sets the foundation of an emerging research 
field, nowadays termed as “structural DNA nanotechnology.”[3] 
Taking advantage of the hybridization of sets of complementary 
oligonucleotides, a first phase of the development concerned 
the emergence of branched DNA-motifs which have sufficient 
mechanical stiffness to be suitable for the assembly of extended 
In the past 35 years, DNA nanotechnology has grown to a highly innovative 
and vibrant field of research at the interface of chemistry, materials science, 
biotechnology, and nanotechnology. Herein, a short summary of the state 
of research in various subdisciplines of DNA nanotechnology, ranging from 
pure “structural DNA nanotechnology” over protein–DNA assemblies, 
nanoparticle-based DNA materials, and DNA polymers to DNA surface 
technology is given. The survey shows that these subdisciplines are growing 
ever closer together and suggests that this integration is essential in order to 
initiate the next phase of development. With the increasing implementation 
of machine-based approaches in microfluidics, robotics, and data-driven 
science, DNA-material systems will emerge that could be suitable for 
applications in sensor technology, photonics, as interfaces between technical 
systems and living organisms, or for biomimetic fabrication processes.
DNA Nanotechnology
supramolecular networks. These devel-
opments have given rise to numerous 
so-called “DNA tiles” that can be used as 
building blocks for the assembly through 
sticky-end cohesion into discrete “finite” 
objects or periodic “infinite” 2D and 3D 
periodic lattices.[4] However, since the 
production of finite DNA nanostructures 
from DNA tiles remained complicated,[5] 
the development of the “scaffolded DNA 
origami” technique by Rothemund[6] is 
to be seen as an important milestone. 
Indeed, this method enabled the break-
through of DNA nanotechology for the 
fabrication of finite, programmable, and 
addressable nanostructures, thereby initi-
ating a second wave of innovation in the 
field.[7] As discussed in Section 2, this set 
the stage to address applications in the life sciences and mate-
rials research.
Also of great importance is the insight that DNA alone 
cannot fulfill the requirements of nanotechnology and materials 
science because nucleic acids offer only limited options, when 
it comes to electrical, optical, catalytic, or mechanical proper-
ties of nanostructured materials and devices.[8] To address this 
issue, early work on the modification of nucleic acid nanostruc-
tures concerning the integration of proteins[9] and nanoparti-
cles[10] has been continuously expanded in order to exploit DNA 
nanostructures as scaffolds for the precise positioning of (bio)
molecular (Section 2) and colloidal (Section 3) components.[11] 
This main stream of developments in DNA nanotechnology 
is flanked by the development in two additional areas, DNA 
polymer chemistry (Section 4)[12] and DNA surface technology 
(Section 5).[13] In this progress report, we will give a brief sum-
mary of the state of the art and highlight challenges in the sub-
fields that have been overcome and still need to be resolved. 
In Section 6, we draw conclusions for possible perspectives of 
DNA-based material systems. We discuss that by convergence 
of the subfields and increasing implementation of machine-
based approaches, DNA-material systems could emerge that 
enable advanced applications in life sciences, technology, and 
even biomimetic fabrication processes.
2. DNA Origami Nanostructures
Rothemund’s “scaffolded DNA origami” technique[6] dramati-
cally simplified the fabrication of finite DNA nanostructures. In 
a simple and fast “one-pot” reaction, hundreds of short oligo-
nucleotides, referred to as “staple strands,” are used to direct 
the folding path of a kilobase long circular single-stranded 
DNA (ssDNA) “scaffold” into an arbitrary shape held together 
Y. Hu, Prof. C. M. Niemeyer
Karlsruhe Institute of Technology (KIT)
Institute for Biological Interfaces (IBG 1)
Hermann-von-Helmholtz-Platz 1, D-76344 
Eggenstein-Leopoldshafen, Germany
E-mail: niemeyer@kit.edu
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/adma.201806294.
© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim. This is an open access article under the terms of the 
Creative Commons Attribution-NonCommercial-NoDerivs License, 
which permits use and distribution in any medium, provided the original 
work is properly cited, the use is non-commercial and no modifications 
or adaptations are made.
Adv. Mater. 2019, 1806294
www.advmat.dewww.advancedsciencenews.com
1806294 (2 of 18) © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
by a periodic arrangement of antiparallel helices connected 
by periodic crossovers. Staple strands as well as the scaffold, 
often the genomic DNA of the bacteriophage M13mp18, can 
be purchased from commercial suppliers. Astonishingly high 
yields of the target structure (typically > 80%) are usually 
obtained, presumably due to the entropic advantage in using 
just a single long scaffold strand for folding. This enables 
cooperative binding processes and displacement of wrong or 
truncated sequences through exchange mechanisms and leads 
to substantial reduction of experimental errors and working 
time because the tight control over stoichiometry and purity of 
the oligonucleotides needed for tile-based assembly[4a,d] is no 
longer necessary. These advantages in practicability, together 
with the capability to generate nanoscaled objects with arbitrary 
shapes and dimensions, have made the scaffolded DNA origami 
technique to an extraordinary robust and powerful tool for the 
fabrication of DNA-based molecular architectures.[14]
2.1. Design Aspects
In his initial description,[6] Rothemund demonstrated the 
assembly of single-layered, planar origami structures, ranging 
from simple figures (triangles, squares, etc.) to more complex 
nongeometric structures, such as a smiley face (Figure 1A). 
As shown in Figure 1B,[6] two neighboring helices are held 
together by a number of periodic crossovers interspaced by 1.5 
helical turns of about 16 bp, thereby forming single layer planar 
sheet of interconnected helices. These design rules also enable 
more complex 2D patterns, such as the shape of China[20] or 
dolphins,[21] and they also allow for fabrication of 3D origami 
nanostructures. For example, preformed planar DNA structures 
that were connected at specific angles by additional crossovers 
were folded stepwise into hollow 3D objects of different geom-
etry, such as prisms,[22] closed polyhedral,[23] or a DNA box with 
a controllable lid.[24]
To overcome a major limitation of single-layer DNA origami, 
that is their relatively low mechanical stiffness, more rigid 3D 
DNA objects were developed by either packing multiple hel-
ices into a space-filling structure[15,25] or by implementation of 
tensegrity rules.[26] Multilayer DNA origami are densely packed 
arrays of antiparallel helices linked together by a 3D arrange-
ment of crossovers, which determines the geometry of the basic 
building block[15] (Figure 1C). A more detailed overview of such 
multilayered structures has been given elsewhere.[11b] Latest 
design approaches rely on computer-based folding of arbitrary 
polygonal digital meshes of target objects[16] (Figure 1D) or 
representation of objects as closed surfaces that are rendered 
as polyhedral networks of parallel DNA double helices 
(Figure 1E).[17] Both methods lead to stable and monodisperse, 
high fidelity 3D structures.
2.2. Scaling up DNA Origami Structures
Many applications in life sciences and materials research 
require the availability of differently sized origami structures 
that can be manufactured in large quantities at reasonable 
cost. The size of DNA origami structures is determined by the 
length of the ssDNA scaffold (typically about 5–10 kb), leading 
to size dimensions in the 100 nm regime. Smaller particles 
can be produced by using short ssDNA circles as “mini 
scaffolds.”[27] Larger particles are more difficult to obtain 
because of limitations occurring from bacterial machinery to 
produce large plasmids. To solve this problem, “superorigami” 
or “origami of origami” superstructures have been devel-
oped.[14] In this strategy, individual DNA building blocks, such 
as DNA tile motifs and origami structures are hybridized into 
assemblies of higher order.[28] Hence, each preformed DNA 
origami serves as an individual motif that is arranged, by 
programmable DNA interactions, inside a larger framework 
of the same or differently shaped origami structures.[29] The 
power of this approach has recently been demonstrated by the 
fractal assembly of micrometer-scaled 2D DNA origami arrays 
with arbitrary patterns[18] and the fabrication of gigadalton-
scale shape-programmable 3D DNA assemblies (Figure 1F).[19]
Typical laboratory scale syntheses nowadays allow produc-
tion of nanomol amounts of DNA origami structures for 
costs of about 1000 €. However, recent developments suggest 
that larger volumes and lower prices can be expected in the 
future. Solid phase DNA oligonucleotide synthesis based 
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on conventional controlled-porous glass columns or multi-
plexed microchip formats allow for large-scale and low-cost 
production of DNA oligomers.[30] Chip-based staple strand 
production can be combined with the use of both strands 
of bacterial plasmids to markedly increase the scale of DNA 
origami production.[31] Furthermore, biotechnological “mass 
production” of DNA origami has recently been demon-
strated by using a scalable and cost-efficient method based 
on bacteriophages.[32] Hence, the above examples clearly indi-
cate that in the next few years almost any particle size and 
sufficiently large amounts of DNA nanostructures will be 
accessible. To achieve this goal, however, it is necessary to 
transfer the current laboratory routines on an industrial scale 
to standard operation procedures with corresponding quality 
controls, as has been done, for example, in DNA synthesis 
and sequencing.[33]
2.3. Addressable Scaffolds for Organization of Non-Nucleic-
Acid Components
It is of utmost importance to recall that DNA origami structures 
possess an addressable surface area of a few thousand nm2 
with a single “pixel” resolution of about 6 nm.[11b] Thus, a 
typical 100 × 80 nm origami structure can be used as a 
molecular pegboard with more than 200 “pixels,” singularly 
addressable with a precision of only few nanometers. One 
of the first applications of this unique addressability utilized 
rectangular shaped origami, wherein staple strands at defined 
positions were capable to specifically bind RNA targets in 
homogeneous sample solutions. After depositing the struc-
tures on mica, bound RNA could be identified by AFM.[34] 
Despite this unprecedented addressability, materials com-
prised entirely of nucleic acids have only limited electrical, 
Adv. Mater. 2019, 1806294
Figure 1. DNA origami structures. A) Single-layered DNA origami shapes and respective AFM (atomic force microscopy) images. B) Illustration 
of design rules: the shape (red) is approximated by parallel double helices joined by periodic crossovers (blue) which fold a scaffold (black) that 
runs through every helix overs (red). A,B) Reproduced with permission.[6] Copyright 2006, Nature Publishing Group. C) Design of multilayered DNA 
origami structures by packing multiple helices into a space-filling structure. Reproduced with permission.[15] Copyright 2009, Nature Publishing Group. 
D) 3D meshes rendered in DNA. Different views of the 3D meshes provided as starting points for the automated design process (1); front face of 
the complete DNA designs (2), and transmission electron microscopy (TEM) images of each structure (3). Scale bar: 50 nm. Reproduced with per-
mission.[16] Copyright 2015, Nature Publishing Group. E) Specification of arbitrary target geometries based on a continuous, closed surface that is 
discretized with polyhedra. Reproduced with permission.[17] Copyright 2016, American Association for the Advancement of Science. F) Self-limiting 
self-assembly of hierarchical 3D origami structures. i) Cylinder model of reactive vertices designed for the self-limiting assembly of a dodecahedron (ii), 
and a representative TEM image of the final structure (iii). Reproduced with permission.[19] Copyright 2017, Nature Publishing Group.
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optical, catalytic, or mechanical functionality. Therefore, appli-
cations of DNA materials usually require functionalization 
with non-nucleic acids.
Direct coupling of small molecules, such as dyes or redox 
active molecules,[35] with distinctive oligonucleotides through 
conventional phosphoramidite chemistry is the simplest way 
to achieve functionality. Numerous studies used this approach 
to generate well-defined nanoscale patterns of dyes, applicable 
for studies of basic principles of, e.g., Förster resonance energy 
transfer (FRET) or as nanorulers for traceable distance meas-
urements and benchmarking of nanoscopy methods.[36] In case 
of 3D origami devices the positioning of the dyes can even be 
carried out with a resolution of less than the Bohr radius.[37] 
3D origami structures equipped with FRET pairs can be 
harnessed as force sensors that allow for precise measurement 
of forces in biomolecular assemblies.[38] Furthermore, coupling 
of lipid molecules to selected staple strands can be exploited 
to assemble origami on lipid membranes[39] or to fabricate 
origami coats for membrane sculpting[40] and nanopore chan-
nels for membrane insertion.[41]
The assembly of proteins on DNA nanostructures is par-
ticularly promising because these biological macromolecules 
reveal intrinsic, evolutionary optimized functionality, such as 
specific binding to biomolecular targets or catalytic conversion 
of ligands and substrates.[42] In particular, arrangements of 
synthetic multienzyme cascades on DNA nanostructures are 
currently attracting much attention because they represent 
spatially interactive biomolecular networks.[43] Representative 
examples include a three-enzyme pathway built to facilitate effi-
cient substrate transfer (Figure 2A)[44] or to demonstrate that 
enzyme pathways can be regulated in a directional fashion by 
the physical control of substrate channeling (Figure 2B).[45] 
Since the synthetic multienzymes can be steered by synthetic 
switches and are not limited in terms of the incorporated bio-
catalytic entities, they could be useful for synthetic biology and 
the next generation of industrial biocatalysis.[46] Furthermore, 
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Figure 2. Functionalized DNA origami structures. A) Three-enzyme pathway composed of malate dehydrogenase (MDH), oxaloacetate decarboxylase 
(OAD), and lactate dehydrogenase (LDH) arranged on a triangular three-point star DNA nanoscaffold. Reproduced with permission.[44] Copyright 2016, 
Wiley-VCH. B) Three-enzyme pathway composed of MDH, glucose-6-phosphate dehydrogenase (G6pDH), and LDH arranged on a rectangular DNA 
origami platform. Reproduced with permission.[45] Copyright 2016, Wiley-VCH. C) Schematic representation of reconfigurable 3D plasmonic AuNR with 
switchable plasmonic properties. Reproduced with permission.[48] Copyright 2014, Nature Publishing Group. D) Artistic illustration of a DNA robot that 
can explore a 2D testing ground on the surface of DNA origami, pick up multiple cargos that are initially at unordered locations, and deliver them to 
specified destinations. Reproduced with permission.[49] Copyright 2017, American Association for the Advancement of Science.
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protein-functionalized DNA nanostructures hold great poten-
tial for other applications in the life sciences, ranging from 
biosensing and drug delivery[14,42,43] to fabrication of bioin-
structive materials and surfaces (discussed below, Sections 4 
and 5) The survey of the respective literature clearly indicates 
that future applications of such DNA-scaffolded multiprotein 
complexes critically depend on means for their reproducible 
production, ideally at large scale under industrial standards. 
While it is evident that methods of recombinant protein tech-
nology along with tailored bioorthogonal coupling chemistries 
will make this possible,[42,47] it is also clear that it will be a long 
and rocky road to implement such complex molecular architec-
tures into routine applications.
Inorganic nanoparticles are used for functionalization of 
DNA origami structures in order to develop new materials 
that can be used for applications, such as nanophotonics, 
plasmonics, and electronics. DNA-based plasmonic nano-
structures are a hot topic in materials research because this 
approach allows to produce complex and hierarchical DNA 
hybrid structures in a highly controllable manner to yield static 
and dynamic molecular devices.[50] Representative examples 
include nanostructures with controlled chirality,[51] reconfigur-
able 3D plasmonic metamolecules (Figure 2C),[48] or plasmonic 
nanoantennas for surface-enhanced Raman spectroscopy.[52] 
As described below (Section 3), much of the ongoing work 
is focused on colloidal gold nanoparticles (AuNP) and gold 
nanorods (AuNR). However, the fabrication of functional 
devices often calls for the integration of nanoparticles made 
of other materials. Current state-of-the-art indicates that inor-
ganic nanoparticles made of silver,[53] semiconductor quantum 
dots,[54] or carbon nanotubes[55] can as well be organized on 
DNA origami scaffolds. Furthermore, 3D origami nanostruc-
tures can also be used as templates and molds to encode the 
size and shape of inorganic nanoparticles.[56] As in the case 
of protein immobilization, robust chemical methods are also 
required here in order to enable production of the inorganic–
organic hybrid structures with high reproducibility on a larger 
scale. This should make it possible to develop a comprehensive 
toolbox in the coming years to produce multicomponent hybrid 
structures for applications in physics and engineering.
2.4. Computational Science and Molecular Robotics
From its very beginning, the genesis of DNA nanotechnology 
was intrinsically tied to the development of mathematical 
models and computational algorithms,[3] be it to design complex 
DNA nanostructures using computer-aided methods[16,17,57] or 
to exploit DNA assembly and amplification in DNA computation 
to process information.[58] Both approaches include dynamic 
DNA systems, in which reversible transition mechanisms 
between various stable or metastable states, such as secondary 
structure conformations, are implemented by means of hybrid-
ization, strand-displacement, cleavage or other processes.[59] 
This can be utilized, on the one hand, for dynamic scaffolds, 
such as the reconfigurable plasmonic metamolecule, shown in 
Figure 2C. On the other hand, metastable origami structures 
can also be exploited for so-called “DNA walkers.” These sys-
tems are latently mobile DNA motifs that follow a prescribed 
path through hybridization and strand displacement.[60] It was 
recently shown that this concept can be used for construction 
of autonomous DNA-based “robots” that can sort nanoparticle 
cargoes on their surface (Figure 2D)[49] or biohybrid rotor–stator 
nanoengines that move along predefined tracks.[61] This work 
gives rise to the hope that molecular machines made from 
DNA will one day be able to perform complex tasks, such as 
the controlled translocation of molecules across barriers,[62] 
the evaluation of the molecular composition of cell surfaces 
for therapeutic purposes,[63] or the assembly of tiny electrical 
and mechanical devices. Given that basic functions have been 
demonstrated in proof-of-concept studies, it seems reasonable 
that the next level of sophistication will be attainable by con-
sequent implementation of molecular bottom-up assembly and 
top-down microengineering. This will make it possible both 
to analyze the basic functions of DNA machines at the single 
mole cule level[64] and to maintain their operation,[65] preferably 
in the form of extended long-range ordered arrays on surfaces 
(see also Section 5.2).
3. DNA-Based Colloid Assemblies
The initial description of using DNA oligonucleotides to 
organize AuNP[10] in 1996 promised a novel approach that could 
readily deliver materials from arbitrary nanoparticles, which 
have novel, size-dependent properties, can be tailored in their 
3D structure, might respond “intelligently” to external stimuli, 
and should open the door to a broad spectrum of applications 
ranging from sensing and catalysis to device fabrication.[8] 
Now, more than 20 years later, we are looking on roughly 
15 000 scientific publications with the keywords “nanopar-
ticle” and “DNA” and we can resume that some of these goals 
have actually been achieved. We here focus on state-of-the-art 
examples regarding the synthesis and assembly of DNA-based 
colloidal assemblies in various dimensions, explain interim 
problems and solutions and conclude that especially chemical 
and engineering methods will need further attention to open 
the door to the development of complex DNA material systems.
3.1. Preparative Synthesis Aspects
One of the major drivers that pushed forward the field of 
DNA-based nanoparticle assembly was the ease with which 
DNA-functionalized AuNP can be produced. Thiolated oligo-
nucleotides are commercially available and they readily chem-
isorb on the surface of citrate-stabilized AuNP under formation 
of a stable covalent sulfur–gold bond. Mirkin and co-workers 
are certainly leading this field of research[66] that has triggered 
biomedical applications of oligonucleotide-functionalized 
AuNP, often dubbed as “spherical nucleic acids.”[67] While thiol 
chemisorption is a possible means for DNA immobilization on 
silver colloids,[68] nanoparticles made of other materials, such 
as quantum dots,[69] iron oxide,[70] silica,[71] polymers,[72] or 
CNT[73] require more sophisticated chemical procedures that 
often lead to lower surface occupancies and stabilities of the 
nanoparticle–oligonucleotide hybrids. Hence, to achieve the 
goal of a comprehensive toolbox for the production of arbitrary 
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multicomponent hybrid structures for applications in physics 
and technology, robust chemical methods have to be developed 
to efficiently convert inorganic colloids into DNA conjugates.
3.2. Assembly in One and Two Dimensions
Depending on the nature of a DNA scaffold, oligonucleotide-
modified particles can be assembled in various dimensions 
ranging from linear chains and wires of nanoparticles (1D) 
over planar arrays and sheets (2D) up to the arrangement in 
3D space (Figure 3A). A relatively simple approach to 1D wire 
assemblies is based on the direct metallization of the DNA 
strand by reducing metal cations (e.g., Ag+, Au3+, Pd2+, Pt2+, 
etc.) bound to the negatively charged DNA backbone. Resulting 
nanowires usually have granular morphologies which can show 
conductive behavior,[74] however, high-quality structures are 
very difficult to prepare in a reproducible manner.[75] To better 
control 1D wire formation and even allow for precisely con-
trolled interparticle spacing, the problems of metallization can 
be overcome through scaffold-assisted assembly of preformed 
nanoparticles.[76] An impressive demonstration of multicom-
ponent hybrid structures has recently been given by the DNA 
origami-based 1D assembly of trimeric Au–Ag–Au nanoparticle 
constructs. These assemblies reveal hotspot-mediated nondis-
sipative and ultrafast plasmon passage that could be important 
for applications in information technology.[53b] As demonstrated 
in various studies,[77] suitable templates for 2D nanoparticle 
arrays can be regular “infinite” arrays of DNA tiles (Figure 3A) 
or DNA origami structures (Figure 3B).[78] Since such arrays 
are highly important for development of 2D layered materials 
for optics and photonics, current and future work regards their 
implementation into extended long-range ordered surface 
arrays (see also Section 5.2).
3.3. Assembly in Space
Since oligonucleotide-modified nanoparticles contain thou-
sands of ssDNA molecules on their surface, they are multi-
valent spheres—hence, Mirkin’s term of “spherical nucleic 
acids”—and do assemble in three dimensions once the DNA 
strands are complementary. In case of noble metal nanopar-
ticles, the DNA-mediated assembly leads to changes in the 
plasmon absorption, and this principle forms the basis of many 
diagnostic tests.[67] Since the “DNA bond”[1] is programmable 
and reversible by nature, variable bond strengths and particle 
spacings can be adjusted, predetermined heteroassemblies of 
different nanoparticles can be formed, and particle aggregates 
can be disassembled by thermal melting,[83] enzymatic cleavage, 
or strand-displacement.[84] However, since the 3D nanopar-
ticle assemblies are usually obtained as amorphous aggre-
gates, the challenge is to devise methodologies that allow for 
assembly of either finite “molecule-like” or infinite “crystal-like” 
nanoparticle assemblies.
One approach to the problem of better controlling the 3D 
assembly is to encapsulate the colloids with a DNA envelope. 
This breaks the symmetry of spherical nanoparticles and allows 
to control the number and position of oligonucleotides.[85] 
Hence, finite assemblies of nanoparticles can now be syn-
thesized by solution-based methods to yield sophisticated 
architectures that resemble satellite- or molecule-like 
superstructures.[54b] The synthetic strategy usually includes sev-
eral steps, which include the use of DNA templates to direct 
bonding geometries (Figure 3C,[80] and 3D[81]) and it provides 
access to even complex nontrivial shapes, such as a nanoparticle 
model of Leonardo da Vinci’s Vitruvian Man.[86] Recently the 
strategy was exploited for fabrication of dynamic nanosystems 
consisting of a core nanoparticle surrounded by small nano-
particle satellites which can undergo conformational changes 
to alter their interactions with living cells.[87] As noted by the 
authors, such strategies could be used for navigating complex 
biological environments. It also seems possible that the imple-
mentation of such constructs in fluidic platforms could lead 
to new approaches for self-organized systems that control the 
growth and repair of DNA materials (discussed in Section 6).
Crystal-like assemblies of DNA–nanoparticles had long been 
proposed, however, first examples were described only more 
than 10 years later from Gang and co-workers[88] and Mirkin 
and co-workers.[89] This breakthrough opened the door to sys-
tematic exploration of the design rules for DNA-programmable 
colloidal crystallization, which nowadays allows to engineer 
AuNP superlattices with almost arbitrary crystal lattice geome-
tries (Figure 3D).[82,90] It is important to realize that such AuNP 
superlattices have high water content. Hence they reveal mate-
rials properties more similar to hydrogels than to solid phase 
crystals. For example, they show dynamic behavior, which 
can be triggered by strand displacement and hybridization.[91] 
While these properties could be advantageous for biological 
applications or dynamic material systems (see above), the 
superlattices are prone to collapse or dissociate in deionized 
water, common organic solvents, at high temperatures, or 
under vacuum. In order to circumvent these disadvantageous 
properties for solid materials, methods need to be developed 
for mechanical stabilization. Current work suggests that this 
can be achieved, for instance, by encapsulation into mechani-
cally supportive silica shells[92] or by stabilization of the 
particle-connecting DNA duplexes with Ag+ ions.[93] Further-
more, since 3D origami lattices are well suited for site-specific 
hosting of nanoparticles,[94] the colloidal assemblies may also 
be stabilized by sequence-specific establishment of covalent 
bonds.[95] Importantly, the implementation of bottom-up col-
loidal assembly in top-down micropatterning processes[96] has 
recently been used to fabricate stable 2D crystal-like large-scale 
assemblies (see Section 5.2).
4. DNA-Based Polymer Materials
Polymers range from synthetic plastics, such as polysty-
rene, to natural macromolecules, such as DNA and proteins. 
They are composed of repeated subunits, which are coupled 
via polymerization of respective molecular building blocks 
(monomers). This leads to high molecular weight products. 
While some natural biopolymers (DNA, proteins, and some 
oligosaccharides) have a precisely determined molecular com-
position and weight, polymers are usually mixtures of differ-
ently sized macromolecules. Therefore, the here described 
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DNA-based polymer materials differ significantly from the 
aforementioned DNA origami nanostructures, which are mono-
disperse particles obtained from only a single well-defined DNA 
scaffold. The concept of fusing synthetic DNA molecules with 
organic polymers goes back to the strategy for altering polymer 
properties by combining different polymer segments within 
one polymer, known as block copolymers.[97] This usually leads 
to microphase separation of the individual polymer compo-
nents, which results in formation of nanosized domains within 
the polymeric materials. As a consequence, novel materials 
Adv. Mater. 2019, 1806294
Figure 3. DNA-based colloid assemblies. A) Schematics of nanoparticle assembly by using various DNA motifs. Reproduced with permission.[79] 
Copyright 2011, Nature Publishing Group. B) 2D arrays of gold nanoparticles directed by lithographically confined DNA origami. Scale bar: 500 nm. 
Reproduced with permission.[78] Copyright 2010, Nature Publishing Group. C) Scheme of three designed clusters assembled from DNA-function-
alized AuNP on correspondingly encoded vertices of octahedral DNA frames. Reproduced with permission.[80] Copyright 2015, Nature Publishing 
Group. D) Self-assembly of methane-like nanoparticle molecules; schematic illustration (i) and cryo-EM image (ii). Reproduced with permission.[81] 
Copyright 2015, American Chemical Society. E) Engineering of lattice parameters and crystallographic symmetry of nanoparticle superlattices through 
particle size and DNA spacer length. Representative examples: face-centered-cubic (fcc), body-centered-cubic (bcc), hexagonal close-packed (hcp) 
superlattices. From left to right, each panel shows a model unit cell (not to scale), 1D and 2D (inset) X-ray diffraction (SAXS) patterns, and a TEM 
image of resin-embedded superlattices. Scale bar: 50 nm. Reproduced with permission.[82] Copyright 2011, American Association for the Advance-
ment of Science.
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properties arise which can be exploited for applications in life 
sciences, organic electronics, and many other fields.
4.1. DNA Block Copolymers
DNA block copolymers (DBCs) are hybrids, comprised of 
synthetic organic polymers and DNA segments. They are 
known since the mid 1980s, when Lemaitre and co-workers 
grafted antisense DNA oligonucleotides onto a poly(l-lysine) 
backbone.[98] In the following, the field has made substantial 
advances with respect to variations in the organic building 
blocks, leading to DBCs with tunable physicochemical, 
mechanical, and biological properties.[97]
To synthesize DBCs, usually presynthesized oligonucleotides 
are grafted onto prepolymerized organic polymers. Covalent 
linkage is achieved by amidation, esterification, disulfide cou-
pling, or, nowadays, bioorthogonal “click” chemistries, which 
are increasingly important for synthetic DNA modification.[99] 
Alternative strategies include continuous on-column syntheses 
using phosphoramidite[100] or N-hydroxysuccinimide[101] 
chemistry and biochemical methods based on polymerase 
chain reaction (PCR)[102] (Figure 4A) or enzymatic restriction/
ligation.[103] For a more detailed assessment of DBC synthesis 
and applications in nanoscience and biomedicine, the survey of 
Schnitzler and Herrmann is recommended.[97]
DNA polymer hybrids are being used, for example, to 
explore fundamental principles of nanosciences because they 
offer new opportunities for studying amphiphilic proper-
ties of supramolecular polymer assemblies and electronic 
interactions therein.[104] Micellar nanostructures can be pre-
pared by self-assembly from DBCs containing hydrophobic 
polymer moieties,[100b,105] and the structural properties can 
be engineered by hybridization with complementary DNA 
sequences (Figure 4B).[106] This gives rise to complex supra-
molecular architectures, such as pH-inducible morphology 
shifting polymers, coil–rod–coil triblock structures and DNA-
dendron fibers.[104,107] Even geometrically challenging amphi-
philic assemblies like cuboid and dumbbell-shaped hetero-
vesicles can be obtained by aid of DNA origami scaffolds.[108] 
Likewise, liposomes can be encapsulated inside rigid DNA 
nanotemplates[109] or rendered to functionally programmed 
fusion cascades.[110] DNA-based approaches were also used to 
prepare sequence-defined polymers,[111] nanopatterned polymer 
sheets of various heights[112] or amphiphilic assemblies from 
semiconducting polymers as a means for creating soft opto-
electronic nanostructures.[113] Along this line, to create molec-
ular-scale electronic or optical wires in arbitrary geometries, 
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Figure 4. Synthesis of DNA block copolymers (DBCs). A) Synthesis of DBCs from organic polymers and variable numbers of DNA strands by using 
PCR. Reproduced with permission.[97] Copyright 2012, American Chemical Society. B) Hybridization of ssDNA-PPO micelles with short oligonucleotides 
yields micelles with a corona of dsDNA (1), whereas base pairing with a long ssDNA results in rod-like micelles (2). The insets are AFM images of 
spherical (top) and rod-like (bottom) micelles. Reproduced with permission.[106] Copyright 2007, Wiley-VCH. C) Routings of oligonucleotide-modified 
polymer chains on 2D DNA origami plates; schematic illustration (left) and AFM image of polymer-modified origami structures. Reproduced with 
permission.[114] Copyright 2015, Nature Publishing Group.
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synthetic polymer wires have been assembled into arbitrary 
routings on 2D DNA origami plates (Figure 4C),[114] and DBCs 
were used for assembly of field-effect transistor devices.[115] 
The latter examples in particular are interesting for realizing 
future perspectives with regard to self-growing and self-healing 
polymer materials for technical applications. Similar as dis-
cussed for nanoparticles, this requires improved (bio)chemical 
methodologies with which organic, inorganic and biological 
molecules can be selectively and efficiently appended.
4.2. Pure DNA Hydrogels
Instead of grafting onto synthetic organic polymers, DNA 
oligonucleotides can also be used to produce pure DNA 
hydrogels.[12a,116] Pure DNA hydrogels are prepared by two 
methods, either the hybridization/ligation of linear[117] and 
branched DNA oligonucleotide building blocks (Figure 5A),[118] 
or else by enzymatic extension of oligonucleotide primers, 
in particular through rolling circle amplification (RCA). The 
resulting DNA hydrogels are entangled networks that often 
reveal shape memory persistence[119] and can be grown enzymat-
ically to mesoscopic structures with distinctive morphologies, 
often dubbed as “DNA nanoflowers” (Figure 5B,C)[120] Polymeri-
zation times range from days for enzymatic procedures, such as 
RCA, to only a few hours for hybridization-based methods, such 
as the recently developed “clamped hybridization chain reac-
tion” (Figure 5D),[121] which can even be conducted on patterned 
surfaces. Owing to the availability of commercial DNA oligo-
nucleotides, the gels can be prepared in macroscopic amounts. 
Because of their high (usually >90%) water content, DNA hydro-
gels are promising scaffold materials in tissue engineering. They 
are perfectly biocompatible and their 3D structure has tissue-like 
elastic properties that allow for effective permeation of oxygen 
and nutrients, which is crucial for cellular colonization.[122]
In addition to organic polymers, as in DBCs, DNA poly-
mers can also be coupled with organic macromolecules, such 
as cucurbit[8]uril,[123] or grafted onto polypeptides[124] and even 
whole proteins.[125] The incorporation of light-sensitive synthetic 
groups, e.g., azobenzene moieties, into DNA hydrogels can be 
exploited for targeted delivery and controlled release of drugs[126] 
or for tumor photothermal immunotherapy.[127] Furthermore, 
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Figure 5. A,B) Synthesis of pure DNA hydrogels by hybridization/ligation of preassembled branched X-, Y-, and T-shaped oligonucleotide structures (A) 
or multiprimed rolling circle amplification (RCA) (B). A) Reproduced with permission.[118] Copyright 2006, Nature Publishing Group. B) Reproduced with 
permission.[119] Copyright 2012, Nature Publishing Group. C) Representative scanning electron microscopy (SEM) images (i), focused ion beam (FIB)-
SEM images of orthogonal cross-sections (ii), and structured illumination microscopy (SIM) images (iii) of “DNA nanoflowers” composed of pure DNA 
(DNF) or endowed with bovine serum albumin (DNF-B) or RNase A (DNF-R). In the SIM images, DNA and proteins are shown in red or green, respec-
tively. Scale bars: 500 nm (top and middle), 1 µm (bottom). Reproduced with permission.[134] Copyright 2017, Wiley-VCH. D) Mechanism of clamped 
hybridization chain reaction (i) and illustration of surface-initiated hydrogel formation and fluorescence images of printed polygon patterns (ii). Scale 
bars: 500 mm (top), 1 mm (bottom). Reproduced with permission.[121] Copyright 2017, Wiley-VCH. E) 3D bioprinting of two complementary DNA bioinks 
that hybridize to DNA–polypeptide hydrogels to yield arbitrarily designed 3D structures. Reproduced with permission.[133] Copyright 2015, Wiley-VCH.
www.advmat.dewww.advancedsciencenews.com
1806294 (10 of 18) © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
DNA polymer composite materials have been produced from 
inorganic materials, such as carbon dots,[128] graphene oxide,[129] 
carbon nanotubes,[130] semiconductor quantum dots,[131] or 
AuNP [126a,127] and magnetic nanoparticles.[132] The addition of 
nanoparticles adds functionality to the DNA hydrogels, whether 
be it mechanical stability,[123] optical traceability,[131] or remote 
controllability by external magnetic fields.[132] This broad spec-
trum of functionalization possibilities is particularly interesting 
for biological applications, ranging from bioinstructive mate-
rials for drug delivery and transfection over encapsulation of 
enzymes and cells to 3D bioprinting of cell populations by addi-
tive manufacturing processes (Figure 5E).[133] In this regard, 
methods would be useful for systematic and facile modification 
of the biological stability and manufacturability of such polymer 
materials. For example, this could be achieved by developing 
recombinant polymerases and other enzymes that can also 
process non-natural DNA analogues (see also Section 5.1).
4.3. DNA Polymer Materials can be Easily Programmed
DNA polymers are attracting so much attention because the 
genetic material allows for rational programming of these soft 
materials through integration of DNA motifs that can be rec-
ognized and processed by functional biological molecules and 
cells. For example, stimuli responsiveness can be easily intro-
duced, e.g., by incorporation of pH-dependent folding motifs[135] 
or enzymatic restriction sites.[136] This enables on-demand disso-
lution of the gels,[136] which is useful to release embedded com-
ponents, such as nanoparticles, enzymes, or cells.[137] Another 
example concerns aptamers, folded nucleic acid motifs that 
exhibit specific binding, that can be easily incorporated to engi-
neer target-responsive[138] and logic gate materials.[139] These can 
be used for sensing[140] or capture of molecules[138] and ions for 
purification purposes.[141] Very importantly, because DNA can 
store genetic information, DNA polymer materials can be engi-
neered to instruct biological systems. Indeed, this approach has 
been used to create protein-producing hydrogels. Such materials 
can instruct the enzymatic machinery of cell lysates in vitro to 
synthesize messenger RNA that is translated into functional 
proteins.[142] By implementation into microfluidic devices, 
these developments could lead to novel material systems 
for the production of a variety of complex molecules, such as 
protein or glycan conjugates. Hence, DNA polymers represent 
a very important class of materials that could be combined with 
the particular properties of nanoparticles and/or DNA origami 
structures in the future to create material systems that are appli-
cable to both life sciences and technology (see also Section 6).
5. DNA Surface Technology
The advent of DNA microarray technology in the course of the 
human genome project in the 1980s led to the evolution of 
sophisticated DNA microarrays, which are nowadays routine 
tools for genotyping and expression profiling in fundamental 
and applied biomedical research.[143] Since DNA is an extraor-
dinary stable molecule, industrial processes for large-scale pro-
duction and use of DNA microarrays that contain up to millions 
of different ssDNA oligonucleotides are fully developed.[144] 
However, the scope of DNA surfaces goes far beyond appli-
cations in genomics and transcriptomics. The method of 
“DNA-directed immobilization” (DDI) of proteins, invented in 
the early 1990s,[9] opened up the DNA chip platform for the 
analysis of proteins and other non-nucleic acid molecules.[13,145] 
DDI takes advantage of surface-bound capture oligonucleotides 
to selectively bind sets of proteins tagged with complementary 
oligonucleotides (Figure 6A). It is a very mild process because 
surface microstructuring with DNA is fully separated from 
surface functionalization with delicate proteins. The latter 
can be conducted under chemically mild, physiological condi-
tions, which do not harm the sensitive tertiary, and quaternary 
structures of proteins. Additional advantages of DDI include 
multiplexing capabilities,[146] high surface-coating density, and 
the option to regenerate the DNA surface by simple denatura-
tion protocols.[147] In more than 20 years, hundreds of research 
papers have demonstrated the advantageous utility of the DDI 
method,[145] of which we here present selected examples that are 
related to the aspects of DNA-based materials described above.
5.1. Protein-Decorated DNA Surfaces
Solid substrates containing microarrays of proteins are of utmost 
importance for sensing, biomedical diagnostics, and proteome 
research.[149] DDI-based protein decoration is not limited to 
glass or polymer surfaces. It can also be used for silicon, gold 
and other materials. This enables plasmonic detection of small 
molecules,[150] electrochemical screening of enzymes[151] or the 
study of electron transfer processes in between proteins and 
metals.[152] For proteome research, DDI on conductive silicon 
substrates is used.[153] Importantly, as demonstrated in proteomic 
studies,[154] synthetic peptide nucleic acid (PNA) oligomers can 
as well be used for DDI. This draws attention to a generally 
important point: DNA-based materials are increasingly produced 
with synthetic DNA analogs, e.g., PNA[155] or locked nucleic acids 
(LNA),[156] in order to increase physical and biological stability.[157]
For future perspectives of DNA-based material systems, it is 
important to emphasize that the DDI method is fully compat-
ible with microfluidic platforms. This enables (bio)functionali-
zation of previously assembled, closed flow systems,[158] along 
with reduction of sample and reagent sizes, and improvements 
in assay stability and processing times. These advantages have 
been demonstrated for the analysis of biomarkers in lab-on-a-
chip devices, point-of-care diagnostics, and compartmentalized 
biocatalytic systems.[46,159] Hence, the integration of DDI and 
microfluidics will play a crucial role in the future development 
of material systems (see also Section 6).
5.2. Nanomaterials on DNA Chips
The use of nucleic acid hybridization for functionalization of 
bulk materials is not limited to proteins but can be readily 
extended to small molecules, such as peptides,[154b] glycans,[160] 
or hormones[150] as well as to inorganic nanoparticles. The latter 
is of particular interest for the self-assembly of DNA-based mate-
rials. For example, groundbreaking work of Mirkin on the DDI 
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of AuNP[161] has led to a whole suite of bioanalytical assays for 
detection of nucleic acids and proteins.[67,162] Other nanoparticles, 
such as semiconductor quantum dots,[163] CNT,[164] or the broad 
variety of silica nanoparticles (SiNP),[71] are as well amenable to 
the DDI approach. For example, self-assembled 2D micropatterns 
of oligonucleotide-functionalized, fluorescent dye-encoded core/
shell SiNP on glass substrates can be used for improved adhe-
sion and guidance of eukaryotic cells on technical surfaces.[71]
In addition to applications in biomedical research, colloidal 
self-assembly on surfaces opens the door to materials and device 
fabrication.[165] The approach can be used to prepare electronic 
circuits, as demonstrated by selective hybridization of AuNP 
in electrode gaps. Subsequent electroless silver deposition on 
the AuNP bridges the gap and establishes electrically conduc-
tive contacts.[166] By using multifunctional DNA-AuNP bearing 
different oligonucleotide addresses (Figure 6B),[167] crosslinked 
2D AuNP layers with adjustable interparticle distances can be 
assembled on surfaces.[148,168] The electrical properties of such 
layers then depend on interparticle spacing.[169]
Recent advances in DNA-directed colloid assembly on 
surfaces include methods for patterned deposition of nano-
materials on DNA surfaces to integrate self-assembly with 
top-down methodologies.[170] Many individual origami struc-
tures can be captured and aligned on patterned surfaces.[171] 
This allowed to produce large-area spatially ordered arrays of 
AuNP arranged on the lithographically confined DNA origami 
Adv. Mater. 2019, 1806294
Figure 6. DNA surface technology. A) Schematic representation of DNA-directed immobilization (DDI). Reproduced with permission.[145] Copyright 
2014, Elsevier Inc. B) DDI of bifunctional DNA-AuNP (D2-Au) leads to crosslinked colloid layers in which the particle’s center-to-center distances 
depend on the length of the crosslinking oligonucleotide (arrow). Reproduced with permission.[148] Copyright 2005, Wiley-VCH. C) Schematic illustra-
tion and SEM images of oriented superlattices of two and three-layer nanoparticle architectures prepared in microfabricated polymer pores. Scale bar, 
300 nm. Reproduced with permission.[96] Copyright 2018, American Association for the Advancement of Science.
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patterns (Figure 3B).[78] The fabrication of large materials 
surfaces with highly defined long-range ordered nanoscaled 
objects can also be achieved by using top-down microfabricated 
poly mer pores for the LNA-mediated bottom-up assembly of 
complex plasmonic nanoparticle architectures (Figure 6C).[96] 
These methodologies provide platforms for the systematic study 
of light–matter interaction in nanoparticle-based materials.
The above described works illustrate the potential of col-
loidal surface assembly for manufacturing of 2D layered mate-
rials. This class of materials displays a large anisotropy to their 
bonding, electrical and/or magnetic properties. Therefore, it 
is of tremendous interest for an enormous breadth of fields, 
ranging from semiconductor technology, electronics, and 
energy storage over photofunctional and catalytic devices to 
biomedical applications.[172]
5.3. DNA Surfaces for Cell Biology
The DDI method is particularly well suited for the patterning 
of living cells on solid surfaces. Such cell microarrays are 
important for tissue engineering, diagnostics, assays in drug 
development, and fundamental studies in cell biology.[173] To 
enable site-selective cell attachment onto DNA surfaces, short 
DNA oligonucleotides can be bound directly to the membrane 
of living cells by a variety of mild chemical methods.[145] Alter-
natively, arrays of ligands with specific affinity for receptors 
on the cell surface can be prepared by DDI, and the resulting 
patterns can be used for selective cell adhesion.[174] Further-
more, DNA-directed patterning of single cells can be achieved 
by using the atomic force microscope for top-down mechanical 
positioning of individual cells.[175] The DNA-based approaches 
have been exploited for electrochemical metabolic analysis of 
single mammalian cells on gold electrodes,[176] the analysis of 
intercellular signaling,[177] the multiplexed patterning of single 
cells for tissue engineering,[173a] the activation of natural killer 
cells,[178] or for switch-like, light-controlled perturbations inside 
living cells.[179]
Importantly, the potential of DNA-based surfaces goes far 
beyond patterning and assembly of single cells when ligand 
arrays with subcellular dimensions are prepared to enable 
precise functional manipulation of small regions inside living 
cells.[180] To this end, ligand arrays of <5 µm diameter feature 
size are fabricated by, e.g., combined dip-pen nanolithography 
printing and DDI assembly processes. The ligands specifically 
bind epitopes of transmembrane receptors in the plasma mem-
brane of adhered cells. This leads to recruitment and concen-
tration of the receptors on the micropatterned ligand arrays 
(Figure 7A). The approach has been used for the analysis of 
native transmembrane receptor signaling,[180a] as well as for the 
generation of protein-interaction arrays inside living cells that 
express synthetic bait-presenting artificial receptor constructs 
(Bait-PARCs, Figure 7B).[180b]
The power of DNA surfaces as tools for fundamental 
research in biomedicine can even be enhanced by implemen-
tation of DNA nanostructures. DNA-encoded surfaces can be 
used for site-specific immobilization and assembly of DNA 
double-crossover (DX) motifs, which are equipped with pro-
truding arms that serve to anchor the resulting DNA lattices 
in a programmable orientation on the solid support.[181] Using 
DNA origami structures instead of the DX tiles, the approach 
was used to create a novel platform for analysis of the preorgan-
ization of cellular membrane receptors. These are frequently 
geometrically constrained, and they often organize in supramo-
lecular assemblies before or as part of their response to ligand 
binding.[182] Investigation of these processes requires tech-
nologies for fabrication of ligand arrays with precisely defined 
nanoscale geometries. This can be achieved with multiscale 
origami structures as interface for cells (MOSAIC),[183] wherein 
ligand-decorated origami structures are immobilized on sub-
cellular micropatterns (Figure 7C). In a proof-of-concept, the 
MOSAIC method was used to establish that the activation of 
epidermal growth factor (EGF) receptors in living cells is influ-
enced by the nanoscale geometry of EGF ligands. Hence, this 
example nicely illustrates that by integration of top-down and 
bottom-up methods a full control over the number, stoichiom-
etry, and precise nanoscale orientation of molecules on surfaces 
can be achieved. MOSAIC shows that, in contrast to material 
science applications (see Section 5.2), long range order is not 
required to achieve macroscopic effects in biological systems. 
Therefore, bioinstructive MOSAIC materials can be envisaged 
for applications in the life sciences that cannot be tackled by 
conventional technologies.
6. Discussion
“DNA in a material world”[3]—as illustrated above, this revolu-
tionary idea of Seeman in the early 1980s has indeed become 
today’s reality. We are looking at an impressive number of 
fundamental and application-based research works in this 
innovative field at the crossroads of materials science, biotech-
nology, and nanotechnology, where the original pure research 
on structural DNA nanotechnology had substantially gathered 
momentum by advancement of nucleic-acid-modified proteins 
and nanoparticles.[184] Spurred by complementary develop-
ments in DNA polymer chemistry and DNA surface technology, 
we are now observing a converging field of research that is 
generating a steadily growing number of applications through 
increasing coherence. We would like to emphasize here some 
points that we consider essential for the future prospects of the 
field.
6.1. Integration of Subdisciplines is Necessary for Applications
The merging of the subareas is already evident from many 
examples in this article, such as the use of tile-based assembly 
methods for the production of origami superstructures 
(Section 2.2), the exploitation of recombinant protein tech-
nology to enable functional DNA nanostructures for live science 
applications (Section 2.3), the use of DNA nanostructures for 
creating colloidal superstructures that in turn can be fine tuned 
and functionalized with proteins (Section 3), the implementa-
tion of functional nucleic acid motifs into polymeric materials 
(Section 4), or the integration of DNA-surfaces to enable 
efficient manufacture of heterogeneous superstructures appli-
cable in biology and material sciences (Section 5). Based on 
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these examples, we have illustrated that research on DNA-based 
materials has already produced a first generation of applications 
in sensing and medicine[12a,67,185] and the second generation, is 
already emerging in the form of, e.g., advanced material sur-
faces, smart carriers, and robots for biomedicine[33] or devices 
for plasmonics.[50a,96] In order to open up these and other fields 
of application, the increasing implementation of engineering 
sciences is of great importance.
6.2. Microfluidics, Robotics, and Data-Driven Science
These are key areas of engineering, which are increasingly 
implemented in the production of DNA nanostructures, their 
manipulation, and application. Examples include machine-
assisted production and analysis of DNA molecules[33] and 
nanoparticles,[186] or microfluidic platforms for manipulation 
of DNA nanostructures[187] and handling and analysis of DNA 
chips.[13,144b,145] Indeed, microfluidics should be regarded as 
a key enabling technology, because it offers an extraordinary 
high degree of control over temperature profiles and diffusion-
based mixing[188] along with an excellent connectivity to high-
throughput liquid handling, robotics, (in-line) analytics, and 
data acquisition.
The latter point is of great relevance because end-to-end auto-
mated technology platforms, covering the entire process from 
synthesis to functional analysis, are capable to deliver enor-
mous amounts of data. This “big data” can be used, in a “data-
driven science” approach,[189] to gain new insights into complex 
processes that are not accessible by experiment or simulation. 
At the moment, intensive work is being conducted on the 
development of end-to-end automated platforms for synthetic 
organic chemistry[190] and synthetic biology[191] as well as for 
biocatalysis[46] and materials research.[192] Taking into account 
that i) DNA-templated synthesis has emerged as an almost rou-
tine tool for materials discovery[193] and ii) DNA nanotechnology 
is intrinsically tied to data sciences (Section 2.4),[57,58c] it is the 
next logical step to develop technical platforms that can be 
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Figure 7. DNA surfaces for investigation of intracellular processes. A) Total internal reflection fluorescence microscopy (TIRFM) images indicate the 
colocalization of cellular epidermal growth factor (EGF) receptors (green) on micropatterns of DNA-immobilized EGF ligands (red). Scale bar, 10 µm). 
Reproduced with permission.[180a] Copyright 2013, Wiley-VCH. B) Bait-presenting artificial receptor constructs (Bait-PARCs) are used to transfer a sur-
face-bound micropattern into living cells to enable analysis of the interaction with fluorescently labeled prey proteins. Reproduced with permission.[180b] 
Copyright 2013, Wiley-VCH. C) Multiscale origami structures as interface for cells (MOSAIC). i) General principle of MOSAIC wherein protein-decorated 
DNA origami nanostructures are site-specifically immobilized on DNA micropatterns (green in (iii)). EGF-modified DON constructs (such as 5-far in 
(ii,iv)) were used to establish EGFR activation depends on nanostructural features, as quantified by immunohistological staining (red spots in (iii)) and 
statistical evaluation of activated spots/cell (n) in (iv)). Reproduced with permission.[183] Copyright 2015, Wiley-VCH.
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used for the automated development of customized DNA-based 
material systems. As explained below, such systems could, in 
the long run, lead to the development of better technical mate-
rials and more sustainable production processes.
6.3. Scale-Bridging Manufacturing and Compartmentalization 
will Open Up New Horizons
Nature shows impressively that systems of almost incredible 
complexity can be created with minimal energy consumption 
but maximal capabilities for programmable replication, repair, 
regulation, and environmental responsiveness. The living sys-
tems are hierarchically organized ranging in size from nanom-
eters of molecules to meters of higher organisms. In order to 
equip these biosystems with their extraordinary complexity and 
functionality, nature has invented “compartments” as essential 
construction elements (e.g., supramolecules, organelles, cells, 
tissues, and organs). These hierarchical systems are based on 
cross-scale constructions that arise from self-organization under 
nonequilibrium conditions. With this strategy, even the integra-
tion of molecular quantum systems is possible.[194] In the case 
of technical systems, top-down microengineering gives access 
to numerous products with dimensions in the low micrometer 
range, however, to further reduce the size, manufacturing pro-
cesses become much more complex, energy-demanding, and 
expensive. Therefore, it is of utmost importance for the future 
to develop material systems with which biological construction 
principles—scale-bridging construction from the sub-nanom-
eter to the macroscopic range, compartmentalization, and self-
organization—can be mimicked and implemented to devise new 
smart products and resource-saving manufacturing processes.
6.4. DNA-Based Material Systems are Suitable  
for this Daunting Task
Due to their chemical structure, DNA materials can undoubt-
edly be used to build scale-spanning structures ranging from 
the atomic regime of base pairs to the 100 nm regime of 
origami structures (Section 2). In a bottom-up approach, the 
rational design and addressability of nucleic acid nanostruc-
tures can be used for tailored mesoscopic polymer materials, 
which has already been demonstrated for shape and size control 
of amphiphilic assemblies (Section 4.1).[108,109] Furthermore, 
ongoing work is already focusing on the combination of top-
down and bottom-up fabrication methods to integrate supra-
molecular DNA structures into micrometer-scale functional 
units (Section 5), and these scale-bridging approaches have led 
to first examples of novel sensors for the analysis of cells,[183] 
nanophotonic superlattices,[96,171b] or nanoscale robotics con-
trolled by microelectronics.[65] Due to their scale bridging 
character and their excellent biocompatibility, DNA materials 
should also be useful for refined biointerfaces that intimately 
connect technical microdevices with the nanoscale circuitry 
of living organisms.[195] Last but not least, since DNA-based 
materials can be produced using nucleic acid-metabolizing 
and modifying processes, they should also be amenable for 
self-organization processes under nonequilibrium conditions. 
Therefore, and by taking advantage of the rapid developments 
of synthetic biology,[33] it seems possible that the further devel-
opment of DNA-based material systems can even lead to bio-
mimetic production processes with which complex functional 
goods can be manufactured.
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